About US
Contact us
-
UK NICE grants Technology Appraisal Guidance for Sanofi’s Praluent (alirocumab)The UK National Institute for Health and Care Excellence (NICE) has granted Technology Appraisal Guidance (TAG) for French pharmaceutical company Sanofi's latest cholesterol-lowering treatment, Pralue2016/6/23
-
US NHRC commences clinical trial of norovirus vaccine at RTCThe US Naval Health Research Centre (NHRC) has launched a clinical trial at Recruit Training Command (RTC) in a bid to assess the effectiveness of the first norovirus vaccine in reducing outbreaks of2016/6/22
-
US NHRC commences clinical trial of norovirus vaccine at RTCThe US Naval Health Research Centre (NHRC) has launched a clinical trial at Recruit Training Command (RTC) in a bid to assess the effectiveness of the first norovirus vaccine in reducing outbreaks of2016/6/22
-
Modality Solutions' Partner Bioconvergence® Rebrands as Singota™ SolutionsLife-sciences contract service provider BioConvergence has rebranded as Singota Solutions to respond to its client's needs. As part of the transition, the company expanded its services in line of CEO2016/6/21
-
Indian firm Zydus Cadila purchases two ANDAs from TevaIndian pharmaceutical company Zydus Cadila has acquired two abbreviated new drug applications (ANDAs) from Israeli-American pharmaceutical company Teva. The two ANDAs are being sold out by Teva as a2016/6/21
-
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, tooNEW ORLEANS--Johnson & Johnson’s Invokana is already coming up big for the company as a treatment for Type 2 diabetes. And the pharma giant recently got some encouraging signs that it may one day2016/6/20
-
Teva pulls migraine patch Zecuity on reports of burning, scarringSo much for the $114 million Teva shelled out to get its hands on Zecuity developer NuPathe. After less than a year on the market, the Israeli drugmaker is pulling the migraine patch. Monday, the com2016/6/20
-
NIH-funded study finds proper maternal folate levels reduce childhood obesityA study led by the National Institutes of Health (NIH)-funded researchers has revealed that proper maternal folate levels during pregnancy may protect children from a future risk of obesity, especiall2016/6/17
-
Researchers discover heart drug Darapladibm can reduce diabetes related blindnessResearchers at University College London (UCL) and Queen's University Belfast have found that a drug Darapladibm, which was originally developed to treat cardiovascular disease, has the ability to red2016/6/17
-
New survey reveals UK failing to meet European standards for lung cancer treatmentData collected from a new survey of 100 doctors has revealed that the treatment of patients with advanced lung cancer in the UK has failed to meet desired European standards. The doctors who are spec2016/6/16